Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹444 Cr₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹444 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹444 Cr
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹444 Cr
-66.40
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,585.8 Cr -3.4% -6.6% -10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-3.4%

-6.6%

-10.1%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses